O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
576
Exelixis
EXEL
$10.2B
|
ST
Silvan Tuerkcan
| $37.88 | $37 |
2%
downside
| Outperform | 5 years ago |
|
577
Cooper Companies
COO
$13.5B
|
SL
Steven Lichtman
| $68.09 | $85 |
25%
upside
| Perform | 5 years ago |
|
578
CrowdStrike
CRWD
$105B
|
SE
Shaul Eyal
| $417.63 | $140 |
66%
downside
| Outperform | 5 years ago |
|
579
DocuSign
DOCU
$16.1B
|
KI
Koji Ikeda
| $79.86 | $300 |
276%
upside
| Outperform | 5 years ago |
|
580
Palo Alto Networks
PANW
$130B
|
SE
Shaul Eyal
| $194.46 | $50.84 |
74%
downside
| Outperform | 5 years ago |
|
581
Merit Medical Systems
MMSI
$5.51B
| $92.97 | $50 |
46%
downside
| Outperform | 5 years ago |
|
|
582
Boston Scientific
BSX
$159B
| $107.22 | $43 |
60%
downside
| Perform | 5 years ago |
|
|
583
InterDigital
IDCC
$7.43B
|
IZ
Ian Zaffino
| $287.80 | $90 |
69%
downside
| Outperform | 5 years ago |
|
584
Autodesk
ADSK
$69.5B
|
KI
Koji Ikeda
| $326.37 | $300 |
8%
downside
| Outperform | 5 years ago |
|
585
Trade Desk
TTD
$25.5B
|
BS
Brian Schwartz
| $52.07 | $45 |
14%
downside
| Outperform | 5 years ago |
|
586
Baxter International
BAX
$12.5B
|
SK
Suraj Kalia
| $24.42 | $100 |
310%
upside
| Outperform | 5 years ago |
|
587
Fiverr
FVRR
$875M
| $23.70 | $74 |
212%
upside
| Outperform | 5 years ago |
|
|
588
Nice
NICE
$8.67B
|
SE
Shaul Eyal
| $140.41 | $200 |
42%
upside
| Outperform | 5 years ago |
|
589
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $95 |
64%
upside
| Perform | 5 years ago |
|
|
590
Kura Oncology
KURA
$713M
| $8.22 | $27 |
228%
upside
| Outperform | 5 years ago |
|
|
591
Allogene Therapeutics
ALLO
$255M
| $1.15 | $55 |
4,683%
upside
| Outperform | 5 years ago |
|
|
592
Hewlett Packard
HPE
$31B
| $23.52 | $13 |
45%
downside
| Outperform | 5 years ago |
|
|
593
Fortinet
FTNT
$60.4B
|
SE
Shaul Eyal
| $78.83 | $32 |
59%
downside
| Outperform | 5 years ago |
|
594
RBC Bearings
RBC
$12.2B
|
CG
Christopher Glynn
| $387.48 | $83 |
79%
downside
| Outperform | 5 years ago |
|
595
Interparfums
IPAR
$3.63B
| $113.10 | $36 |
68%
downside
| Neutral | 5 years ago |
|
|
596
Novavax
NVAX
$1.28B
| $7.90 | $38.50 |
387%
upside
| Outperform | 5 years ago |
|
|
597
Aldeyra Therapeutics
ALDX
$334M
| $5.56 | $12 |
116%
upside
| Outperform | 5 years ago |
|
|
598
RingCentral
RNG
$2.89B
|
BS
Brian Schwartz
| $31.94 | $270 |
745%
upside
| Outperform | 5 years ago |
|
599
PayPal
PYPL
$65.2B
| $68.26 | $140 |
105%
upside
| Outperform | 5 years ago |
|
|
600
Match Group
MTCH
$9.18B
| $38.17 | $95 |
149%
upside
| Outperform | 5 years ago |
|